September 15, 2023
1 min watch
Save
VIDEO: Highlights in neovascular AMD from ASRS
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SEATTLE — In this video, Aleksandra V. Rachitskaya, MD, FASRS, discusses some of the key highlights in neovascular age-related macular degeneration from the ASRS annual meeting.
Some of the highlighted research includes studies evaluating high-dose aflibercept and real-world studies providing data on faricimab.
In addition, Rachitskaya, an assistant professor in the department of ophthalmology at Case Western Reserve University’s Cleveland Clinic Lerner College of Medicine, touches on preclinical research on CRISPR technology and early trial results looking at intravitreal injections of gene therapy.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Rachitskaya reports serving as a consultant and speaker for Genentech/Roche.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.